TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
-3.2%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$3.36B
AUM Growth
-$1.68B
(-33%)
Cap. Flow
-$1.35B
Cap. Flow
% of AUM
-40.17%
Top 10 Holdings %
Top 10 Hldgs %
28.65%
Holding
6,080
New
403
Increased
1,949
Reduced
2,725
Closed
953
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$249M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$21M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$18.3M |
| 4 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$15.6M |
| 5 |
Exxon Mobil
XOM
|
+$14.9M |
Top Sells
| 1 |
Apple
AAPL
|
+$120M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$94.5M |
| 3 |
Microsoft
MSFT
|
+$85.3M |
| 4 |
NVIDIA
NVDA
|
+$83M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$38.8M |
Sector Composition
| 1 | Technology | 19.99% |
| 2 | Financials | 9.87% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Healthcare | 7.96% |
| 5 | Communication Services | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Clean Energy Fuels
CLNE
$577M
| $10.3K | ﹤0.01% |
6,498
-7,086
| -52% | -$11.3K |
|
3652
Fennec Pharmaceuticals
FENC
$240M
| $10.3K | ﹤0.01% |
1,695
-501
| -23% | -$3.05K |
|
3653
Larimar Therapeutics
LRMR
$349M
| $10.3K | ﹤0.01% |
4,801
+1,951
| +68% | +$4.2K |
|
3654
Middlefield Banc Corp
MBCN
$255M
| $10.3K | ﹤0.01% |
369
-950
| -72% | -$26.6K |
|
|
AOMR
3655
Angel Oak Mortgage REIT
AOMR
$231M
| $10.3K | ﹤0.01% |
1,081
-869
| -45% | -$8.28K |
|
3656
Structure Therapeutics
GPCR
$1.24B
| $10.3K | ﹤0.01% |
595
-3,481
| -85% | -$60.3K |
|
3657
Rimini Street
RMNI
$417M
| $10.3K | ﹤0.01% |
2,957
-1,760
| -37% | -$6.13K |
|
3658
GoPro
GPRO
$364M
| $10.3K | ﹤0.01% |
15,520
-8,385
| -35% | -$5.56K |
|
3659
James River Group
JRVR
$233M
| $10.3K | ﹤0.01% |
2,449
+250
| +11% | +$1.05K |
|
3660
Escalade
ESCA
$167M
| $10.3K | ﹤0.01% |
672
-1,616
| -71% | -$24.7K |
|
3661
Red River Bancshares
RRBI
$433M
| $10.3K | ﹤0.01% |
199
-947
| -83% | -$48.9K |
|
3662
Black Diamond Therapeutics
BDTX
$180M
| $10.3K | ﹤0.01% |
6,621
-1,659
| -20% | -$2.57K |
|
3663
Kodiak Sciences
KOD
$487M
| $10.3K | ﹤0.01% |
3,659
+1,950
| +114% | +$5.47K |
|
3664
Consumer Portfolio Services
CPSS
$180M
| $10.2K | ﹤0.01% |
1,181
-268
| -18% | -$2.32K |
|
3665
Cross Country Healthcare
CCRN
$430M
| $10.2K | ﹤0.01% |
687
-550
| -44% | -$8.19K |
|
3666
Kaltura
KLTR
$260M
| $10.2K | ﹤0.01% |
5,435
+187
| +4% | +$352 |
|
3667
Biomea Fusion
BMEA
$117M
| $10.2K | ﹤0.01% |
4,790
-48
| -1% | -$102 |
|
3668
XBiotech
XBIT
$80.5M
| $10.2K | ﹤0.01% |
3,148
-1,051
| -25% | -$3.41K |
|
3669
iShares Russell 3000 ETF
IWV
$16.9B
| $10.2K | ﹤0.01% |
32
+30
| +1,500% | +$9.53K |
|
3670
QuickLogic
QUIK
$90.3M
| $10.2K | ﹤0.01% |
1,989
+1,334
| +204% | +$6.82K |
|
3671
Nektar Therapeutics
NKTR
$973M
| $10.2K | ﹤0.01% |
995
+220
| +28% | +$2.24K |
|
3672
KalVista Pharmaceuticals
KALV
$676M
| $10.1K | ﹤0.01% |
879
-5,448
| -86% | -$62.9K |
|
3673
scPharmaceuticals
SCPH
$302M
| $10.1K | ﹤0.01% |
3,851
+338
| +10% | +$889 |
|
3674
Zura Bio
ZURA
$124M
| $10.1K | ﹤0.01% |
7,848
+4,134
| +111% | +$5.33K |
|
3675
Reynolds Consumer Products
REYN
$4.83B
| $10.1K | ﹤0.01% |
424
-17,219
| -98% | -$411K |
|